Home / Precision Medicine (page 20)

Precision Medicine

Surescripts Supports White House to Advance Precision Medicine Initiative

ARLINGTON, Va.–(BUSINESS WIRE)–Today Surescripts, the nation’s leading health information network, announces its support of President Obama’s Precision Medicine Initiative (PMI). Surescripts will participate in the White House Precision Medicine Initiative Summit and pledge its support to provide Surescripts’ infrastructure and technology to help the Precision Medicine Initiative aggregate the medical …

Read More »

Baxalta and Precision Biosciences Form Global Genome Editing Collaboration in Immuno-Oncology

BANNOCKBURN, Ill. & DURHAM, N.C.–(BUSINESS WIRE)–Baxalta Incorporated (NYSE: BXLT), a global biopharmaceutical leader dedicated to delivering transformative therapies to patients with orphan diseases and underserved conditions, and Precision BioSciences, the genome editing company, today announced a global collaboration to develop a broad series of allogeneic chimeric antigen receptor (CAR) T …

Read More »

Regen BioPharma Completes Preclinical Experimentation of its Novel siRNA NR2F6 Checkpoint Inhibitor

SAN DIEGO, February 24, 2016 /PRNewswire/ — Regen BioPharma, Inc., (OTCBB: RGBP) and (PINK: RGBP) announced today completion of experiments, in collaboration with Dr.Santosh Kesari, demonstrating immunological mechanisms of its novel NR2F6 gene silencing approach.  Subsequent to these experiments, the Company has begun the process of compiling an Investigational New Drug …

Read More »

ImmunID and Memorial Sloan Kettering Partner to Validate Cancer Immunotherapy Companion Diagnostic

GRENOBLE, France, Feb. 23, 2016 /PRNewswire/ — ImmunID, the immune companion diagnostics for precision medicine company, today announces that it has just signed a master collaboration agreement with Memorial Sloan Kettering Cancer Center (MSK) in New York, United States. MSK is the world’s oldest and largest private cancer center. It has ranked …

Read More »

Myriad Expands Diagnostic Research Collaboration with TESARO and Merck

SALT LAKE CITY, Feb. 22, 2016 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced a strategic research collaboration with TESARO and Merck, known as MSD outside the U.S. and Canada, to help identify potential responders to an investigational combination drug therapy …

Read More »

$1 Million Investment to Launch Grand Challenge to Develop a TDP43 Biomarker for ALS

WASHINGTON, Feb. 10, 2016 /PRNewswire-USNewswire/ — The ALS Association, in partnership with ALS Finding a Cure, is pleased to announce the Grand Challenge to generate a biomarker to track TDP43 aggregation. The successful team(s) with the most developed plan will receive up to a $1 million investment. ALS is a progressive …

Read More »

GSK and Adaptimmune Expand Immunotherapy Collaboration

GlaxoSmithKline plc (LSE/NYSE: GSK) and Adaptimmune Therapeutics plc (Nasdaq: ADAP), a leader in the use of T-cell receptor (TCR) engineered T-cell therapy to treat cancer, today announced that the companies have expanded the terms of their strategic collaboration agreement to accelerate Adaptimmune’s lead clinical cancer programme, an affinity enhanced T-cell …

Read More »

Geisinger Researchers Discover 17 Genes Related to Brain Disorders

DANVILLE, Pa., Jan. 27, 2016 /PRNewswire-USNewswire/ — A recent study led by a team of researchers at Geisinger Health System’s Autism & Developmental Medicine Institute (ADMI) identified 17 new genes causing autism and other related brain disorders, including intellectual disability/developmental delay, epilepsy, attention deficit hyperactivity disorder, schizophrenia, and bipolar disorder. …

Read More »

New Precision Medicine Guidelines Aimed at Improving Personalized Cancer Treatment Plans

Tuesday, Jan 19th, 2016, Cleveland: A committee of national experts, led by a Cleveland Clinic researcher, has established first-of-its-kind guidelines to promote more accurate and individualized cancer predictions, guiding more precise treatment and leading to improved patient survival rates and outcomes. These new guidelines are changing the traditional approach of …

Read More »